LINEAR INSULATION LIMITED
Company number 05983963 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: LINEAR INSULATION LIMITED
1. Financial Health Score: A-
Explanation: Linear Insulation Limited exhibits excellent overall financial health, characterized by robust asset growth, strong liquidity, and a solid equity base. The company has successfully navigated previous financial strains (notably in 2019 when net assets were perilously low at £183k) and has since undergone a remarkable recovery and expansion. The score of A- rather than a pristine A reflects mild symptoms of "growing pains"—specifically, a significant buildup in trade debtors and a substantial outstanding director loan, which could cause circulatory issues (cash flow constraints) if left unchecked.
2. Key Vital Signs
- Net Asset Growth (Bone Density & Muscle Mass): £2.65 million (2025) vs £1.77 million (2024). This represents a staggering 49.5% year-on-year increase. The company's structural strength has grown immensely since the precarious days of 2019, indicating a highly profitable core operation.
- Current Ratio (Blood Pressure): 2.35:1 (Current Assets of £4.39M / Current Liabilities of £1.87M). This is well above the healthy baseline of 1.5:1. The company has more than enough liquid resources to cover its short-term obligations, indicating no immediate risk of financial shock.
- Cash Position (Hydration Levels): £608,297. While slightly down from £672,374 in 2024, this remains a very healthy fluid reserve, especially considering the massive capital expenditure and dividend payouts during the year.
- Leverage (Cholesterol Levels): Total liabilities of £1.87M against total assets of £4.39M results in a debt-to-asset ratio of roughly 42%. This is a very manageable level of "bad cholesterol"—the business is not over-leveraged and is not choking on excessive debt.
- Employee Growth (Metabolic Rate): Average employees grew from 26 to 28, aligning with the company's physical expansion and increased operational capacity.
3. Diagnosis: Robust Health with "Growing Pains"
The patient has an exceptionally strong constitution. Over the last six years, Linear Insulation Limited has transformed from a fragile state (net assets of just £183k in 2019) to a highly muscular and robust entity (£2.65M in 2025). The underlying profitability is clearly very strong, as evidenced by the retained profits swelling the P&L reserve.
However, a closer examination of the symptoms reveals some localized stress points associated with rapid growth:
- Arterial Plaque (Swelling Debtors): Trade debtors have more than doubled from £487k to £1.17M, and other debtors have jumped from £986k to £1.53M. While this is typical of a rapidly growing construction installation business, it represents money clogging the arteries rather than flowing through the system as cash. If these debts become unrecoverable, they could cause a minor blockage.
- Self-Medication (Director Advances): The outstanding director advances total £803,810. While directors often take advances against future dividends or profits, this is a significant extraction of capital. It acts as a financial bloodletting that reduces the company's immediate working capital. Given that £295k in dividends was also formally paid, the total extraction by owners is substantial and must be carefully monitored.
- Capital Investment (Organ Transplants): The company invested £280k in tangible assets (plant, machinery, and buildings) this year, disposing of older assets. This shows a healthy reinvestment in the operational "organs" of the business to maintain competitive fitness.
4. Recommendations: Preventative Care & Maintenance
To maintain this excellent health trajectory and mitigate the risks associated with rapid growth, the following preventative measures are prescribed:
- Improve Circulation (Credit Control): With trade debtors doubling, it is vital to ensure this "plaque" doesn't harden into bad debts. Implement stricter credit control procedures—invoice promptly, chase payments rigorously, and consider tightening credit terms for slower-paying clients. You want that £1.17M to flow into the bank account as swiftly as possible.
- Monitor Director Loan Health (Regulate Extraction): The £803k director loan is a significant item on the balance sheet. Ensure this is formally documented with clear repayment schedules. If the loan is written off or remains outstanding for too long, it can trigger severe tax penalties (under the Corporation Tax Act 2010, Section 455) which would act as a sudden, painful shock to the system.
- Maintain Cash Reserves (Stay Hydrated): While cash is currently healthy at £608k, the combination of high debtors and director loans means liquidity could dry up quickly if trade payments slow down. Maintain a minimum cash buffer to cover at least 2-3 months of operating expenses to protect against unforeseen market downturns.
- Review "Other Debtors" & "Investments": The balance sheet shows £1.53M in "Other debtors" and £1.08M in "Other current asset investments". Given these are large sums relative to the business size, management should regularly assess these for impairment to ensure the asset values are genuine and recoverable.